SOPHiA GENETICS (SOPH) Operating Expenses (2020 - 2025)

SOPHiA GENETICS's Operating Expenses history runs 6 years deep, the most recent figure standing at -$23.3 million for Q4 2025.

• In Q4 2025, Operating Expenses fell 6.89% year-over-year to -$23.3 million; the TTM figure through Dec 2025 stood at -$86.8 million (down 6.71% YoY), while the FY2025 annual figure was -$86.8 million, down 6.71% from the prior year.
• Operating Expenses came in at -$23.3 million for Q4 2025 at SOPHiA GENETICS, down from -$22.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of -$14.6 million in Q2 2021 to a low of -$23.9 million in Q1 2022.
• A 5-year average of -$20.9 million and a median of -$21.8 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 99.8% in 2021 and sank 62.14% in 2022, its largest moves.
• SOPHiA GENETICS's Operating Expenses stood at -$19.3 million in 2021, then declined by 7.26% to -$20.7 million in 2022, then dropped by 11.14% to -$23.0 million in 2023, then grew by 5.3% to -$21.8 million in 2024, then dropped by 6.89% to -$23.3 million in 2025.
• According to Business Quant data, Operating Expenses over the past three periods registered -$23.3 million, -$22.0 million, and -$20.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison